About: Alpine Clinical Research Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alpine Clinical Research Center Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

facility in Boulder, United States

Attributes	Values
rdf:type	Item
description	facility in Boulder, United States (en)
rdfs:label	Alpine Clinical Research Center (en)
skos:prefLabel	Alpine Clinical Research Center (en)
name	Alpine Clinical Research Center (en)
ROR ID	wds:Q30269570-C561FD14-F0C3-4017-B627-43E33A11CCF4
ROR ID	00qnrkz57
instance of	wds:Q30269570-FDBB7184-1159-44A1-BC7E-0165E4041C32
instance of	facility
country	wds:Q30269570-0357E565-F603-461C-81B7-55252235283C
country	United States of America
inception	wds:Q30269570-CEFE0FC7-BAB6-41BB-8287-B7E78578F49B
inception	1994-01-01 00:00:00Z (xsd:dateTime)
located in the adm...erritorial entity	wds:Q30269570-25E6C587-32B7-4D30-80E2-71421F31BDB1
coordinate location	wds:Q30269570-1B7E9859-DE54-4E7E-9878-A6CCA4995B0B
official website	wds:Q30269570-DD706221-8E86-4FF9-811E-2B93400EAA24
located in the adm...erritorial entity	Boulder
coordinate location	POINT(-105.243816 40.037996)
official website	http://www.alpineresearch.com/
GRID ID	wds:Q30269570-FD579EA6-73B1-4172-B643-77C0538B8CD3
GRID ID	grid.476992.7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30269570
is research site of	Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension An Open Label Study of FT218 in Subjects With Narcolepsy Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine Experimental Medication For the Treatment of Generalized Anxiety Disorder Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris ESCAPE Migraine Trial A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia Crossover Post-herpetic Neuralgia (PHN) Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx A Phase 3 Study of Tanezumab for Chronic Low Back Pain AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
is research site of	wds:Q64397000-BF67190C-509C-47A1-B4C5-8D321562327E wds:Q63578725-AABDC41B-163C-4A93-88AF-DB1B4F0F010F wds:Q64150116-9DEDCAAD-DA77-4B59-B90E-64FBD3F7946A wds:Q66075246-997DA0D5-82B6-484A-BBDF-8AB0073003E3 wds:Q65389718-F930136E-D49A-4D2D-9696-95A8C11BCE3A wds:Q66028337-4806FA0E-BC6F-4C06-9B38-D6791F20E951 wds:Q65358475-DF2DA2F6-1F27-4E2F-B121-8AADF499CFD9 wds:Q64642512-D1EC21E2-CF9A-4506-BB59-95C742A9ECB7 wds:Q66066701-19BBB9AF-C422-4EE1-873B-9EA77577E5B2 wds:Q113886960-3A21F2D6-69E3-45F8-B041-F721DBA9009C wds:Q61922098-F7951CB1-63B1-40DE-BEA9-B22ACE6973DD wds:Q64709488-6F22A851-6E71-4CA7-B37C-2085E0C1E398 wds:Q62030770-5DEA1B82-EC1E-43FE-9655-7430E0D360BD wds:Q65390105-7416634F-AFB9-4BC8-B2BB-E149DE4E03D5 wds:Q66068029-12FFE4AD-DA2E-4D60-836C-F1BF128D087C wds:Q66059275-D07A69D4-22E6-4512-9617-C8993DC2A025 wds:Q63571224-3487221B-0E1F-481D-A389-FCF15917DA53 wds:Q113892490-18FB7166-1EA8-4242-B3BE-5FBE92B37AD4 wds:Q64724300-A907263E-74B5-47A8-B5F1-151087C4E0CA wds:Q64727455-2FF09B48-5A97-4508-BA82-C5C0179B974A wds:Q65355521-39459941-178B-4F1F-BA88-501813EA9470 wds:Q63228865-7E93EE49-651E-400E-B004-D16E975EDE7C wds:Q65540832-11ED05E6-5A8F-4A4C-81BD-4AA66D06E3B4 wds:Q66044957-1924C01F-C96B-4B10-9FBB-88844F4429D1 wds:Q113936112-0FA49623-F3C3-4F84-94D4-AFCC2F43BE0C wds:Q63813871-B8B52281-585C-4175-AE97-0BD295BEE61F wds:Q64725833-D84FE7A1-C5CA-4ECC-A9D4-BD02A4B5F170 wds:Q65336005-35CD3924-A483-430A-BE64-10CA4229E3D6 wds:Q64635945-81DC8257-4007-490B-82A1-B36660015386 wds:Q64673178-634ED23A-85FE-4A15-8D16-605B3CFD1176 wds:Q65545540-31CA45FA-9251-4792-BE8F-79FD68EB3E56

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software